Clinical Trials Logo

Clinical Trial Summary

Persons with Diabetes (PWDs), at minimum of (n=120) will successfully collect their urine and test with two Ascensia strip products. The products are: Ketostix and Keto-Diastix.


Clinical Trial Description

Persons with Diabetes (PWDs), at minimum of (n=120) will successfully collect their urine and test with two Ascensia strip products. 1. Demonstrate that untrained PWDs can successfully read the Instructions for Use and use Ketostix and Keto-Diastix reagent strips for Urinalysis with no training. Urine samples from the PWDs will be collected and then tested by the PWD and will be compared to the reference assay results. 2. Demonstrate Ease of Use by PWDs with a Labeling Evaluation Survey for Ketostix and Keto-Diastix reagent strips. Participants will respond to a survey using a 5 point Likert scale with 5= Strongly Agree, 4= Agree, 3=Neutral, 2=Disagree, 3=Strongly Disagree. 3. Demonstrate that persons with diabetes (PWDs) can successfully test urinalysis control solutions. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06053593
Study type Observational
Source Ascensia Diabetes Care
Contact
Status Completed
Phase
Start date July 24, 2023
Completion date November 30, 2023

See also
  Status Clinical Trial Phase
Completed NCT03131609 - Avoiding Bacterial Contamination of Clean Catch Urine Cultures in Ambulatory Patients in the Emergency Department
Terminated NCT03801720 - UltraWee: Ultrasound Bladder Stimulation N/A
Completed NCT02751671 - Point-of-care Ultrasound for Clean-Catch Urine Collection in Young Children N/A
Recruiting NCT06018831 - Urine and Ultrasound Screening for Kidney Disease in Children N/A